Lataa...
Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
Abstract. Riociguat is a soluble guanylate cyclase stimulator approved for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). This randomized, double-blind, placebo-controlled study investigated the pharmacokinetics of riociguat and its...
Tallennettuna:
| Julkaisussa: | Pulm Circ |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
University of Chicago Press
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860529/ https://ncbi.nlm.nih.gov/pubmed/27162629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685019 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|